Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ketamine-assisted Psychotherapy in Adolescents With PTSD
NCT06378528Phase 1Suspended
- Sponsor
- University of Wisconsin–Madison
- Start
- Sep 2026
- Primary completion
- Sep 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of ketamine in post-traumatic stress disorder (PTSD), sponsored by University of Wisconsin–Madison. Primary endpoint: Summary of Adverse Events Attributable to Ketamine Administration up to 10 weeks. Started Sep 2026; status: suspended.
02
Drugs
ketamine
03
Conditions
post-traumatic stress disorder (PTSD)
Beyond the preview
Go deeper on NCT06378528.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06378528.